Patterson-UTI Energy, Inc. logo PTEN - Patterson-UTI Energy, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 28
HOLD 18
SELL 6
STRONG
SELL
0
| PRICE TARGET: $13.43 DETAILS
HIGH: $16.00
LOW: $12.00
MEDIAN: $13.00
CONSENSUS: $13.43
UPSIDE: 8.83%

Stock News

Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer

Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer

First FDA-approved IHC assay identifies patients who may be eligible for combination treatment with TRUQAP® (capivasertib) BURLINGTON, N.C., Aug. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the nationwide availability of Roche's VENTANA® PTEN (SP218) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) to determine PTEN protein loss, also known as PTEN deficiency, in tumors of patients with prostate adenocarcinoma.

Aug 04, 2026 03:00 AM prnewswire.com
Here Are Friday’s Top Wall Street Analyst Research Calls: Blackstone Mortgage, Boston Scientific, Edison International, Ford, GoDaddy, International Paper, Roblox, Saia, and More

Here Are Friday’s Top Wall Street Analyst Research Calls: Blackstone Mortgage, Boston Scientific, Edison International, Ford, GoDaddy, International Paper, Roblox, Saia, and More

After a week of wild swings that rattled portfolios and left investors guessing, Wall Street analysts are already reshuffling their ratings on Friday morning, with some surprising cuts and upgrades across sectors from utilities to gaming that could reshape how you think about your positions.

Jul 31, 2026 03:51 AM 247wallst.com

Price Targets